300642.SZ

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Medical - Devices

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$511M	-42.7%	$0.00	$0.00–$0.00	—	0

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Earnings surprises

Beat consensus in 0 of the last 5 reported quarters

Reported	Est. EPS	Actual	Surprise
2026-08-25	$0.19	$0.11	-43.4%
2026-04-24	$0.31	$-0.03	-111.2%
2026-04-24	$0.31	$-0.01	-104.3%
2025-04-18	$0.17	$0.06	-63.1%
2024-09-29	$0.17	$0.11	-35.6%

DCF fair valuemodel estimate

Intrinsic value

$3.94

Price

$16.25

Implied downside

-76%

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
300642.SZTellgen Corporation	$16.15	-0.62%	$2.6B	—
002022.SZShanghai Kehua Bio-engineering Co., Ltd.	$5.55	+0.00%	$2.9B	—
002932.SZWuhan Easy Diagnosis Biomedicine Co.,Ltd.	$15.24	-0.39%	$3.5B	—
300289.SZBeijing Leadman Biochemistry Co.,Ltd.	$5.66	+0.18%	$3.1B	—
300314.SZNingbo David Medical Device Co., Ltd.

Tellgen Corporation

Tellgen Corporation is dedicated to the creation, manufacturing, and supply of in-vitro diagnostic (IVD) solutions, serving both the Chinese domestic market and a global clientele. Their extensive product catalog includes cancer detection markers, test kits for human papilloma virus (HPV), ToRCH diagnostic assays, Y-chromosome microdeletion screening kits, and sophisticated multiplex immunoassay systems. The company, founded in 2003, operates from its headquarters in Shanghai, China.

www.tellgen.com

Employees: 683
IPO / List date: Apr 21, 2017
HQ: CN

Held by traders on TradeandTell

No one on the platform currently holds 300642.SZ.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in 300642.SZ as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded 300642.SZ yet.